hsa-miR-20a

ncRNA information

ncRNA name

hsa-miR-20a

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

LRIG1

Cancer information

Cancer name

Gastric Cancer

Cancer site

Stomach

Treatment information

Treatment type

Chemotherapy

Drug

Adriamycin/Vincristine

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

We demonstrated that the miR-20a/LRIG1 regulated GC cell MDR through epidermal growth factor receptor (EGFR)-mediated PI3K/AKT and MAPK/ERK signaling pathways.

Tissue resource

paired samples of primary gastric cancer and adjacent normal tissues

human gastric cancer cell lines SGC7901

human gastric cancer multidrug-resistant cell lines SGC7901/VCR

human gastric cancer multidrug-resistant cell lines SGC7901/ADR

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

Xijing Hospital

the State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases

Country

China

Continent

Asia